
1. j transl med. 2010 nov 3;8:109. doi: 10.1186/1479-5876-8-109.

targeting inflammation hcv-associated hepatocellular carcinoma: role 
the prevention treatment.

castello g(1), costantini s, scala s.

author information: 
(1)oncology research centre mercogliano (crom), mercogliano (av), italy.
beppe.castello@gmail.com

epidemiological, preclinical clinical studies demonstrated chronic
inflammation induced hepatitis c virus (hcv) crucial hepatocellular
carcinogenesis. interaction hepatocytes microenvironment regards 
virus, inflammatory immunocompetent cells, chemo- cyto-kines, reactive
oxygen species (ros) nitric oxide (no), generating cell transformation. we
suggest hepatocarcinoma (hcc) model targeting of
microenvironment determine neoplastic transformation. present review focuses 
on: role inflammation carcinogenesis, clinical impact hcc and
the inadequacy actual therapy, chemoprevention targeting the
microenvironment.

doi: 10.1186/1479-5876-8-109 
pmcid: pmc2991329
pmid: 21047421  [indexed medline]

